Peer Review History
| Original SubmissionJuly 16, 2021 |
|---|
|
PONE-D-21-23200Measuring Avoidance and Emotion Regulation in Children – Development and Evaluation of the Bochum Avoidance and Emotion Regulation Scale for Children (BAER-C)PLOS ONE Dear Dr. Lippert, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. I thank the authors for their patience and the reviewer for their comments on the manuscript. I was hoping to receive a second set of comments, but I was unable to secure an additional review. I have also reviewed the manuscript myself. I see that there are some strong aspects of the work. There is a clear motivation for the work and connections with models of emotion regulation. Here, you also extend those models to be applicable to children. The reviewer is very clear and pointed in their identification of several conceptual and analytic issues in the work. Their comments are comprehensive, so I will not reiterate them. I want to be clear that all will need to be addressed for a revision to be successful. I also have some queries about the measure. I did not see a description of the number of response options or the degree of skew in the indicators. If the items are rather skewed, that could explain some of the poor model fit. Relatedly, there are estimation options available that provide model fit information from EFAs (including within lavaan). Thus, the transition from CFA to EFA does not fully remove the need to report complete model fit information. Please submit your revised manuscript by Dec 23 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Thomas M. Olino Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Please include a copy of the scale developed in this study, in both the original language and English, as Supporting Information. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The present study represents an important potential advance in theoretically driven measurement instruments for emotion regulation, and the instrument shows promise. However, the introduction would benefit from more clarity about the narrow focus of the measure, and more detail about the EFA and CFA need to be provided in the results. The most significant concerns are around the combination of two separate samples and the lack of validity evidence for the measure. Specific feedback follows. Introduction • It would be helpful to include examples of behavioral avoidance, safety behavior, and thought suppression when they are mentioned in the introduction • The title of the questionnaire is confusing because it implies avoidance is separate from emotion regulation but the questionnaire was developed along the theory that avoidance is part of the process of emotion regulation. I appreciate the goal of the measure though, to develop a more appropriate assessment of the Gross process model, as my opinion is that the current Gross questionnaire (focusing on reappraisal and suppression) does not adequately assess this model! This has always bothered me, so I really appreciate these authors’ approach. That said it is a specific aspect being tested here, avoidance as it pertains to the process model, so however the title of the questionnaire could potentially capture that would be best. I’m not sure why avoidance strategies as they pertain to response modulation were excluded, but again, as long as it’s made clear throughout that this measure pertains to anticipatory strategies only, it’s not necessarily an issue. Also, to narrow it down even further, the questionnaire just assesses regulation of anxiety specifically! It’s going to be tough to capture this very specific narrow approach in the title of the measure so I’m not sure how to address all this. “Avoidance-based anticipatory emotion regulation strategies for anxiety scale for children” is more than a little clumsy! Maybe a short title for the measure but with an explanatory clause in the title of the article would help (e.g., ‘______’: A measure of ______ for children). Method • It’s unclear why these extra items were generated “In addition, items concerning the subjective skill to handle anxiety and the acceptance of anxiety were generated and all but one were worded without negations” as well as the extra 30th item. Were these items included in the analyses? If so, which items were they? • It’s strange that the CFA was just mentioned in passing in the method section rather than given a full section in the results with all the appropriate information provided. • The differences in administration and characteristics between the two samples are a little concerning. Ideally the samples would be analyzed separately and assessed for any differences between them, or at least this would be done and noted in a footnote if no differences were found. • Were all participants given potential reading assistance or only in the second sample where it is noted? • The confirmatory factor analysis is mentioned again in passing in the statistical analysis section, and described as unsuccessful—this is confusing, and once again, more detail should be provided about these analyses (at the very least, more of the fit statistics, and an indication of exactly what model was tested). A little more detail is provided in the results section but it’s unclear each time it’s mentioned previously that it will be discussed later in the paper and even when it comes up in the results section more information should be provided. It’s an unusual strategy to do the CFA first and then do an EFA when the CFA fails. Usually an EFA would be conducted first and the CFA to confirm the structure that was uncovered. Although the measure was developed based on theory, it still seems the traditional analytic process would make more sense. The CFA should also generally be done in a separate sample than the EFA. So, ultimately, it might make more sense to leave the CFA out of this paper entirely and conduct a follow up study to confirm the EFA structure in a new sample. Results • More information should be provided on the EA in the determining of the number of factors – numeric results from the parallel analysis, the scree plot, the Eigenvalues and % of variance explained, etc. • Exactly how much would the overall reliability decline if item 1 was removed, because ideally items with low factor loadings should not be retained? • It’s unclear whether item 9 was retained on both subscales. • Item 23 does not seem to make sense on the reappraisal subscale and may need to be removed • Although it states in text this information is in Table 2, I don’t see the factor intercorrelations in the table. • The lack of correlations with the SDQ internalizing should be mentioned under the convergent validity header (as that was their intention), not divergent. Thus, convergent validity is only partially confirmed. Similarly, the correlations with adaptive subscale should be listed under divergent validity. There is a problem with the divergent validity evidence, as there is not evidence of divergent validity for this scale. • It’s unclear why some analyses were done with the samples separated and some were not. • It seems like it should say p < .001, not p > .001. Discussion • Unfortunately, I would not agree that the construct has been confirmed, given the poor divergent evidence. Ultimately though, the biggest issue is there are not enough validity measures in the study, so it’s difficult to draw conclusions. There should be validity measures that are more other existing emotion regulation and strategy questionnaires, not just validity measures of psychopathology. It’s one thing to show relations to externalizing problems where none were expected – as the authors state, ER is a transdiagnostic factor that is related to a lot of pathology – however, avoidance should be less related to externalizing, so it’s still concerning. However the correlations with adaptive coping are more concerning, given the lack of other relations to other ER measures among which to contextualize this. • The authors should interpret why the security scale possibly ended up splitting into two separate factors. • There should be a more thorough discussion of limitations. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-23200R1Bochum Assessment of Avoidance-based Emotion Regulation for Children (BAER-C): Development and Evaluation of a New Instrument measuring Anticipatory Avoidance-based Emotion Regulation in anxiety eliciting situationsPLOS ONE Dear Dr. Lippert, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The Reviewer and I see many improvements to the manuscript based on the initial set of comments. The Reviewer provides several additional suggestions for you to consider to make your analyses and interpretation of the results more rigorous. Please consider each of the suggestions carefully. I anticipate that I should not need to send your revision for further review, but will review the revision myself. Please submit your revised manuscript by Jul 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Thomas M. Olino Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors did a commendable job in revising the paper in line with the reviewer and editor feedback. I appreciate how responsive they were, and I feel the analyses are greatly improved and clarified. I am pleased with the new name the authors have given to the scale and to the paper, which greatly clarifies the target of this approach. I think the authors have also modified their conclusions and recommendations reasonably in the discussion. Below I have several further suggestions for clarifications in the revised paper, regarding the new analyses primarily. These suggestions, though numerous, are fairly straightforward and I am confident the authors can address them. - Although the items were later dropped, it’s still not clear why these additional items (subjective skill, acceptance of anxiety) were generated since they don’t fit with the model. This information should be provided because the reader doesn’t know yet when they are mentioned that they will later be dropped, so it’s still confusing to read. Another idea could be to relegate this information to a footnote later on so it doesn’t take on such a high priority when describing the scale – but even in that case more information should be provided about why these items were developed. - The statement about “for scoring…” that is on page 10 line 197 of the tracked changes copy should be moved to after the results section because we can’t determine how the questionnaire should be scored until the factor structure information is presented. - For validity, I would refer to it as construct validity, not criterion validity (as it’s not being compared to a gold standard measure of the same construct). Also, it would be useful to provide validity information in both samples separately (and then together, if desired). - Low reliability of SDQ scales should be mentioned in the limitations as a potential issue with attenuating correlations. - Please provide examples of the maladaptive and adaptive strategies on the FEEL-KJ. Considering that in the results the measure was correlated positively with both adaptive and maladaptive scales, it would be helpful to contextualize why that might be by knowing more about what distinguishes the items. - On line 378, I’m not sure why it says the differences between the samples were used to ‘check for criterion validity’. - What is meant by three items were removed because of low discriminatory power? The way the results section reads, this happened before the factor analysis, so is this based on something other than factor loadings? - More specific information about how much each removed item lowered the overall consistency (or at least what it was before and after the three items were removed) should be provided. - It is my experience that eigenvalue and % of variance information is generally presented in the manuscript itself, so that’s ideally where I would like to see it – but I’ll defer to the editor if they feel this material is best suited for supplementary materials. - In the eigenvalue table, the values for factor 6 should be provided so that it’s clear the simulated data eigenvalue is higher than the original at that point. - The scree plot should be provided. - The eigenvalue data is not necessarily all pointing to the same conclusion – which is not to say that I disagree with the five factor solution, especially in light of the parallel analysis and the % of variance explained – but it’s also noteworthy that there are three factors with eigenvalues above 1, and there’s a huge drop between factors 1 and 2 (though hard to tell in proportion without the scree plot), so a 1 or 3 factor solution would also be defensible. These potential solutions and the decision making process justifying going with the five factor solution should be described in text. - The loadings for item 1 and 25 should be provided even though they were removed (and can be italicized or otherwise indicated in the table if necessary for clarity). - There shouldn’t be model fit statistics TLI and RMSEA provided for an exploratory factor analysis. - It isn’t indicated that the authors intend users to create an overall total score across all 21 items, so if this doesn’t make conceptual sense, then an overall alpha shouldn’t be provided across all 21 items (or if it is intended, this should be clarified). - Is the validity with the SCAS calculated combining both samples? Since the other measures are only in one sample or the other, this measure should be analyzed separately for each sample. - Do the SCAS-C and SDQ go in opposite directions, in terms of how they’re scored? Please clarify in the methods section how they’re coded because in Table 4 it’s unclear why the social reassurance scale is correlated in opposite directions with the SCAS-C and the SDQ internalizing…and also whether the correlations with suppression and reappraisal indicate higher levels of externalizing problems. - In the divergent validity section, it should also say that social reassurance did not correlate significantly with externalizing symptoms. - Please also report the chi square value for the CFA model. - The loadings in the CFA should also be reported, either in text, a table, or a figure, whatever is preferable. A figure would be ideal so the structure can be visualized. Were the intercorrelations between the factors modeled (since they were accounted for in the EFA model)? - The comparison between the two samples (3.7) should be presented earlier, before the rest of the results – probably when the rest of the sample characteristics are presented. Section 3.8 should stay where it is. - I think there’s a typo in line 567 “trying that someone is with the child” – maybe there’s a word missing? - In the discussion when the CAMS is referenced, it’s unclear how that’s relevant to a specific discussion of internal consistency. - The statement in the discussion that all avoidance strategies except behavioral were associated with externalizing symptoms does not appear consistent with the results. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-21-23200R2Bochum Assessment of Avoidance-based Emotion Regulation for Children (BAER-C): Development and Evaluation of a New Instrument measuring Anticipatory Avoidance-based Emotion Regulation in anxiety eliciting situationsPLOS ONE Dear Dr. Lippert, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Specifically,
Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Nabi Nazari, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments (if provided): Dear Authors, Please, revise the manuscript according following comments. First: Please, follow the Author guideline. ■ in text citation, use Square bracket [ ], with numbers. ■ add Doi to references. The quality of language is acceptable. However, there are several similar issues. Unnecessary use of prepositions at the beginning or between sentences has reduced the writing quality of the article. "Examples are given below. Please revise the entire text according to these examples. You can also use author services". I suggest you that consult with professional editor. Please, delete numerous unnecessary prepositions or words. 1. Line 51: please revise the sentence. " with Period" is unnecessary and not suitable. 2. Line 61: " Even SO" is unnecessary. Also 20 to 40% is not correct. "20% to 40% " is correct. 3. Line 63: "still" is unnecessary. " Lack" needs article( 'the lack is correct). 4.line 73: authors state" numerous ER strategies". Authors should nake example. 5. Line 77: " Gross (2001)" delete. the citation should moved to the end of the sentence. 6. Line 80: Depete "especially" . 7. Line 80- 85: the paragraph is not relevant, short, and irrelevant to the befor and next Paragraphs. 7. Line 80. The" :" is not suitable. 8. Line 86: delete " albeit". ....................... Following issues are Minor. However, some items are critical. 1. Add legend for tables and figure. 2.The abstract is not informative. Add some statisticall results. 3. Please follow IMRAD. the limitations is correct. Outlook should be deleted. 4. Please, speak about generalizability. 5. The study should be written according to " standard checklist". ● this item is critical. Please attach the STROBE CHECKLUST. 6. The figure should be presented in standard form. The current figure is not scientific. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have been very responsive to the reviews, and I think the scale will make an important contribution to the literature. I believe the paper should be accepted for publication, with the following last few minor suggestions for improvement: • The information justifying the acceptance and subjective skill is good, but the end of the paragraph is still confusing. It still says four subscales with 29 items were created (and then a 30th item), so it’s not clear where the acceptance and subjective skill items went. It looks like the 4 subscales covered 25 items, based on the tables – so I guess I would put the statement ‘four subscales with 25 items were created’ before the information about acceptance and subjective skills, and then state that an additional four items were added to cover these topics. • On line 185 of the tracked changes copy, the word importance doesn’t seem correct. I’m not sure what word is supposed to be there, but that word doesn’t make sense. • You note that validity is examined separately, but on line 216 it states “Finally, to check construct validity both patient and community sample were combined.” I think you mean to say validity was examined in both the patient and community samples? • If the validity correlations presented really are for different samples depending on the measure, it should be made more clear which sample each result is coming from (stated in the results when each set of results is presented). • When I said it wasn’t clear how testing differences between the samples would speak to validity, I meant it should be made more clear what the expectation is and how it would speak to validity (e.g., if scores were higher in the clinical sample this would indicate that the scale accurately measured avoidance based emotion regulation). And actually, that one could be considered criterion validity! I think you can change that particular instance back (or leave it, whatever you prefer). • The explanation added to the discussion regarding choosing the five factor solution over the one or three factor solution should be in the second paragraph of the results section instead. • The CFA figure is very helpful, thank you! One suggestion would be to make the oval for the reappraisal figure bigger, and spell out that word, so that it’s clear the reappraisal and avoidance factors are on the same hierarchical level and correlated with each other (I do see the double headed arrow but the size and orientation make it easy to miss) rather than reappraisal appearing as another lower level factor under avoidance. Reviewer #2: Dear Authors, Thank you for designing this precious study. 1. That is suggested to provide a short description for “anxiety disorders” in first paragraph in INTRODUCTION section. 2. It should be better change “ criterion validity” to “ construct validity”. 3. Please mention examples of the maladaptive and adaptive strategies on the FEEL-KJ. 4. Please more explain why removed three items. 5. chi square value for the CFA model is not reported! Sincerely ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 3 |
|
Bochum Assessment of Avoidance-based Emotion Regulation for Children (BAER-C): Development and Evaluation of a New Instrument Measuring Anticipatory Avoidance-based Emotion Regulation in Anxiety Eliciting Situations PONE-D-21-23200R3 Dear Dr. Lippert, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nabi Nazari, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-23200R3 Bochum Assessment of Avoidance-based Emotion Regulation for Children (BAER-C): Development and Evaluation of a New Instrument Measuring Anticipatory Avoidance-based Emotion Regulation in Anxiety Eliciting Situations Dear Dr. Lippert: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Nabi Nazari Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .